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Abstract p73, a member of the p53 family, has been shown to
exhibit similar biochemical activities to that of p53. However, in
contrast to p53, p73 is rarely mutated in human tumors and p73
mutant mice develop neurological, pheromonal, and inflamma-
tory defects, but not spontaneous tumors. Furthermore, p73
mutant mice are deficient in the physiological control of cerebral
spinal fluid. To determine what mediates these p73 activities,
cDNA subtraction assay was performed to identify cellular genes
that are regulated by p73. We found that aquaporin 3 (AQP3), a
glycerol and water transporter, is regulated by p73. In addition,
we identified a potential p53 response element in the promoter of
the AQP3 gene, which is responsive to p73. This suggests that
AQP3 may mediate the activity of p73 in maintaining cerebral
spinal fluid dynamics. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
p73, a member of the p53 family, shares a considerable
sequence similarity with p53, especially in the transactivation,
DNA binding, and tetramerization domains [1]. p73 is ex-
pressed as at least six di¡erent splicing variants: p73K,
p73L, p73Q, p73N, p73O, and p73j [2,3]. A vN variant of these
p73 proteins has been found, which lacks the N-terminal ac-
tivation domain and is potentially dominant negative [4]. Like
p53, p73 can bind to the p53 response element and regulate
some p53 target genes [2,3]. p73 can also induce cell cycle
arrest and apoptosis [2,3]. However, unlike p53, p73 is not
frequently mutated and p73 mutant mice are not susceptible
to spontaneous tumors [2^4]. Instead, p73 is necessary for the
normal neurological and pheromonal development and the
in£ammatory response [4]. Mutant p73 mice are also abnor-
mal in maintaining spinal £uid dynamics [4].
The aquaporins are a family of small transmembrane water
and/or glycerol transporters. Currently, ten aquaporins
(AQP0^AQP9) have been identi¢ed and are divided into
two groups, ‘aquaporins’ and ‘aquaglyceroporins’. The aqua-
porin group, including AQP0, 1, 2, 4, 5, 6, and 8, is structur-
ally related to the bacterial water channel and highly selective
for the passage of water [5^8]. The aquaglyceroporin group,
including AQP3, 7, and 9, is structurally related to the bacte-
rial glycerol facilitator with an enlarged loop E and permeated
by water, glycerol, and some other solutes [5^8]. AQP3 is
relative weak in the transport of water, but very e⁄cient in
the transport of glycerol and other solutes [9^12]. AQP3 is
initially cloned from the kidney collecting duct and brain me-
ningeal cells [9,10,13] and later found to be expressed in red
and dendritic cells and epithelium cells from a variety of tis-
sues, including tracheal, eye, nasopharyngeal, digestive tract,
and skin [14^18]. Like AQP2 mutant mice, mice de¢cient in
AQP3 are susceptible to nephrogenic diabetes insipidus but
developmentally normal [19]. In an e¡ort to identify cellular
genes that mediate p73 activity, we performed cDNA subtrac-
tion assay and found that AQP3 is regulated by p73.
2. Materials and methods
2.1. Cell culture and cell lines
MCF7 and H1299 cell lines were purchased from American Type
Culture Collection (Rockville, MD, USA). p53-24, p53(R249S)-25,
p73K-2, p73K292-3 and p73L-38, derivatives of the MCF7 cell line
that inducibly express wild-type p53, p53(R249S), p73K, p73K292,
and p73L, respectively, were generated as previously reported [20].
2.2. RNA isolation, cDNA subtraction assay, and Northern blot
analysis
Poly(A)+ RNA was isolated from p73L-38 cells using an mRNA
puri¢cation kit (Pharmacia, Piscataway, NJ, USA). Total RNA was
isolated from cells using Trizol reagents (Life Technologies, Inc., Gai-
thersburg, MD, USA). The cDNA subtraction assay was performed
using the Clontech PCR-select cDNA subtraction kit according to the
manufacturer’s instructions (Clontech, Palo Alto, CA, USA). Sub-
tracted cDNA fragments were cloned into pGEM-T vector (Promega,
Madison, WI, USA). Northern blot analysis was performed as de-
scribed previously [20]. p21 and GAPDH probes were prepared as
described previously [20]. A 615-bp NotI fragment, prepared from
AQP3 cDNA [21], was used to detect AQP3.
2.3. Luciferase assay
A 36-bp fragment (5P-AAGCTAGGTCACCAGCCATGTTCAA-
CAGGCATGTGC-3P) that contains the potential p53 response ele-
ment in the AQP3 promoter was synthesized and cloned upstream of
a minimal c-fos promoter and a ¢re£y luciferase reporter gene [22].
The resulting construct was designated AQP3-Fluc. A 990-bp frag-
ment that contains the potential p53 response element and a 790-bp
fragment that lacks the potential p53 response element in the AQP3
promoter were generated by PCR and cloned into a promoterless
luciferase reporter vector (pGL2-basic) (Promega, Madison, WI,
USA). The resulting constructs were designated APP990 and
APP790. 2 Wg of AQP3-Fluc, APP990, or APP790 was cotransfected
into H1299 cells with 1 Wg pcDNA3 control vector or a vector that
expresses p53, p53(R249S), p73K, p73K292, p73L, or p73L292. 0.1 Wg
of renilla luciferase assay vector, pRL-CMV (Promega), was also
cotransfected as an internal control. The dual luciferase assay was
performed according to the manufacturer’s instructions (Promega).
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2.4. Immunocytochemistry
Cells were plated on four-chamber tissue culture slides. After wash-
ing with PBS, the cells were ¢xed with 10% formalin, permeabilized
with 1% NP-40, and incubated in 15% goat or rat serum to block non-
speci¢c binding. The cells were then stained with anti-p73 (Ab-2,
Oncogene, Cambridge, MA, USA) or anti-AQP3 (Santa Cruz Bio-
technology, Santa Cruz, CA, USA) antibody and examined by £uo-
rescence microscope.
3. Results
To identify novel target genes regulated by p73, the Clon-
tech PCR-select cDNA subtraction assay was performed using
mRNA isolated from the p73L-38 cell line, a derivative of the
MCF7 cell line that inducibly expresses p73L under the con-
trol of a tetracycline-regulated promoter. Several cDNA frag-
ments that may represent genes induced by p73 were isolated.
After DNA sequencing, one subtracted cDNA fragment was
found to be derived from the aquaporin (AQP) 3 gene. To
con¢rm that AQP3 can be induced by p73, Northern blot
analysis was performed using AQP3 cDNA as probe. We
found that AQP3 was strongly induced in p73L-38 cells
when p73L was expressed (Fig. 1, AQP3 panel, compare lanes
5 and 6). AQP3 was also induced by p73K (Fig. 1, AQP3
panel, compare lanes 1 and 2) and weakly induced by p53
(Fig. 1, AQP3 panel, compare lanes 7 and 8). In contrast,
mutant p73K292 and p53(R249S) were incapable of inducing
AQP3 (Fig. 1, AQP3 panel, compare lanes 3, 4 and 9, 10). As
a control, we tested the expression of p21, a well-de¢ned tar-
get gene for both p53 and p73. We found that p21 was in-
duced by p53, p73K, p73L (Fig. 1, p21 panel), but not by
mutant p53(R249S) and p73K292 (Fig. 1, p21 panel).
To determine whether AQP3 is transcriptionally regulated
by p73, we searched for a potential p53 response element that
can be regulated by p73. To do this, we screened a human
bacterial arti¢cial chromosome (BAC) library (The Genome
System, St. Louis, MO, USA) and identi¢ed a clone that
contains the entire AQP3 locus. A region of 3570 nucleotides
in the promoter of the AQP3 gene was sequenced (data not
shown). We found one potential p53 response element (Fig.
2A). This sequence (AAG CTAG gTC acc AGc CATG TTC
aac AGG CATG TgC) contains three half sites with only one
mismatch each (in bold italics) in the non-critical region as
compared to the consensus p53 response element [23,24].
To analyze whether this element is responsive to p53 and
p73, we cloned a 36-bp fragment containing the potential p53
response element upstream of the c-fos minimal promoter and
a luciferase reporter gene [22] to generate a reporter vector,
designated AQP3-Fluc. AQP3-Fluc was cotransfected into
H1299 cells with either a pcDNA3 control vector or a vector
expressing p53, p53(R249S), p73K, p73K292, p73L, or
p73L292. We found that the luciferase activity for AQP3-
Fluc was markedly increased by p53 (52-fold), p73K (52-
fold), and p73L (731-fold), but not by mutant p53(R249S),
p73K292, and p73L292 (Fig. 2B).
Fig. 1. Upregulation of AQP3 by p73. Northern blots were pre-
pared using 10 Wg of total RNA isolated from p73K-2, p73K292-3,
p73L-38, p53-24, or p53(R249S)-25 cells under both the uninduced
(3) and induced (+) conditions. The blots were probed with cDNAs
derived from the AQP3, p21, and GAPDH genes, respectively.
Fig. 2. Identi¢cation of a potential p53 response element in the
AQP3 gene. A: Schematic representation of the AQP3 genomic
structure. The position of the AQP3 transcription and translation
start sites and a potential p53 response element are indicated.
Shown above the genomic structure are the sequence of the poten-
tial p53 response element and the previously characterized consensus
response element. R represents purine, Y pyrimidine, and W ad-
enine or thymidine. Shown below the genomic structure is the loca-
tion of the DNA fragments used to generate two reporter con-
structs. B: The potential p53 binding site in the AQP3 gene is
responsive to p53 and p73, but not to mutant p53 and p73. 2 Wg of
AQP3-Fluc was cotransfected into H1299 cells with 1 Wg of
pcDNA3 control vector or a vector that expresses p53, p53(R249S),
p73K, p73K292, p73L, or p73L292. The fold increase in relative lu-
ciferase activity is a product of the luciferase activity induced by
p53 or p73 divided by that induced by pcDNA3. C: The AQP3
promoter that contains the potential p53 binding site is responsive
to p53 and p73, but not to mutant p53 and p73. The experiment
was performed as in B.
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To determine whether p53 and p73 can regulate the poten-
tial p53 response element in the natural promoter of the
AQP3 gene, we cloned the promoter region of the AQP3
gene into a promoterless luciferase reporter vector (pGL2-ba-
sic). The resulting vectors are designated APP990 and APP790
(Fig. 2A). APP990, but not APP790, contains the potential
p53 response element. We found that the luciferase activity for
APP990, but not for APP790, was increased by p73K (2.6-
fold), p73L (3.1-fold), and p53 (1.7-fold) (Fig. 2C). In con-
trast, mutant p53(R249S), p73K292, and p73L292 were inca-
pable of increasing the luciferase activity for both APP990
and APP790. It should be mentioned that the ability of
p73L to increase the luciferase activity for both AQP3-Fluc
and APP990 was much higher than that by p53 and p73K,
consistent with the strong induction of endogenous AQP3 by
p73L (Fig. 1).
To determine whether the enhanced expression of the AQP3
gene leads to an increased expression of the AQP3 protein in
p73L-expressing cells, we measured the level of the AQP3
protein in cells by immuno£uorescence microscopy. We found
that the level of the AQP3 protein was substantially increased
in p73L-expressing cells as compared to control cells (Fig. 3,
compare A and B). We also found that the AQP3 protein was
localized on the inner plasma membrane (Fig. 3B), as previ-
ously reported [17,25,26]. As a control, we found that p73L
was expressed in the nucleus only when induced (Fig. 3, com-
pare C and D).
4. Discussion
Several studies have shown that AQP3 can be regulated by
the corticosteroid dexamethasone, activated protein kinase C,
and cystic ¢brosis transmembrane conductance regulator in
airway epithelial cells and lung carcinoma A549 cells
[21,26,27]. However, the mechanism by which AQP3 is regu-
lated is still not clear. In this study, we found that AQP3 is
strongly induced by p73 and weakly induced by p53. In addi-
tion, we have identi¢ed a potential p53 response element in
the promoter of the AQP3 gene, which is responsive to p73
and p53.
Although p73 and p53 are highly similar in the DNA bind-
ing domain, we and others have shown that p73 and p53
di¡erentially regulate p53 target genes [28^30]. For example,
14-3-3c is strongly induced by p73 whereas p21 and MDM2
are strongly induced by p53. Thus, AQP3 becomes another
example. Since the cellular target genes are responsible for the
activities of the p53 family members, the di¡erential regula-
tion of cellular genes by the p53 family members may corre-
late with the distinct activities of p53 and p73 [2,3]. Therefore,
AQP3, as a p73 target, may mediate the activity of p73 in
regulating the homeostasis of cerebral spinal £uid. In mice,
p73 is highly expressed in the epithelial cells of the choroid
plexus and the ependymal cells lining the ventricles [4], both
of which participate in regulating cerebral spinal £uid dynam-
ics. Therefore, lack of p73 leads to defects in production or
reabsorption of cerebral spinal £uid, resulting in hydrocepha-
Fig. 3. Immunological detection of the AQP3 protein in p73-expressing cells. p73L-38 cells were uninduced or induced for 24 h, ¢xed in 4% for-
malin, and stained with anti-AQP3 or anti-p73 antibody. A: Control cells stained with anti-AQP3 antibody. B: p73L-expressing cells stained
with anti-AQP3 antibody. C: Control cells stained with anti-p73 antibody. D: p73L-expressing cells stained with anti-p73 antibody.
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lus [4]. Among the aquaporin family, AQP3 and AQP4 are
expressed in the brain ependymal cells [10,14]. Since AQP4 is
not induced by p73 (data not shown), further studies are
needed to determine whether lack of AQP3 induction by
p73 contributes to the hydrocephalus in the p73 mutant mice.
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